🐂 NVDA $41M Second-Wave Whale — Same $190C Sep-18 as Yesterday, Now $82M Cumulative and Still Buying

📅 June 2, 2026 | 🔥 Unusual Activity Detected | 🤝 BLOCK CROSS

---

🎯 The Quick Take

Someone — almost certainly the same desk that bought 10,000 NVDA $190 September calls yesterday for $43.3M — just dropped another $41M on the EXACT same contract today at 12:36 ET, this time paying $44.80/contract (≈$1.50 more as NVDA spot inched from $223.87 to $225.35). That brings the two-day cumulative commitment to ≈$82M on a single deep-ITM $190 September-18 call. Yesterday's OI was confirmed: OPRA open interest rose from 80,662 to 90,018 (Δ +9,356), locking in that print as a fresh long. Today's second-wave print is almost certainly the same thing — a desk that wants to OWN ≈940,000 shares of NVDA equivalent through September-18, with NVDA Q2 FY27 earnings on August 26 sitting squarely inside the expiry window.

---

📊 Company Overview

NVIDIA Corporation (NVDA) is the world's dominant AI accelerator manufacturer and the most valuable semiconductor company in history:

• Market Cap: ≈$5.5 trillion (≈24.3B shares × $225)
• Industry: Semiconductors / AI Accelerators / Electronic Computers
• Current Price: ≈$225.35 (June 2, 2026, 12:36 ET)
• Primary Business: Data-center GPUs (Blackwell / Vera Rubin), AI networking (NVLink, Spectrum-X), professional visualization, automotive, and edge AI
• Fiscal Q1 FY27 Revenue: $81.6B (+85% YoY) — the largest absolute revenue beat in semiconductor history

NVDA has compounded from a $300B company in early 2023 to a $5.5T titan riding the global AI infrastructure buildout. Data Center revenue now represents ≈92% of the total, and the forward roadmap — Vera Rubin NVL72 volume in Q4 2026, GB300 Blackwell Ultra in production — keeps the growth narrative intact through at least mid-2027.

---

💰 The Option Flow Breakdown

📊 What Just Happened

The Tape — June 2, 2026 @ 12:36:00 ET:

Flow type: 🤝 BLOCK CROSS (SINGLE_LEG_CROSS_NON_ISO) — a single broker matched a buyer and a seller and crossed the block off the open order book. There is a known counterparty on the other side. This is deliberate institutional positioning, not an aggressive lit-market sweep.

The two-day picture:

Key details about today's print:

• 🐂 Paid up: $44.80 today vs $43.30 yesterday — the buyer is NOT bargain-hunting; they're chasing exposure as NVDA rises
• 📊 Vol 9,400 vs OI 90,000 — volume is ≈10% of open interest; size alone cannot prove this is a fresh open (OI confirmation arrives tomorrow ≈06:30 ET)
• 🎯 Deep in the money: Strike $190 vs spot $225.35 — the call is ≈$35.35 ITM, delta ≈0.95. This is a leveraged stock-substitute, not a speculative gamma bet
• 💡 Intrinsic vs extrinsic split: $44.80 price = $35.35 intrinsic + ≈$9.45 extrinsic. The buyer is paying ≈$9.45/contract of time value, or ≈$8.7M of pure premium bleed across 9,250 contracts

---

✅ OI UPDATE (2026-06-03) — 2ND-DAY BTO DOUBLE-DOWN CONFIRMED

Last updated: 2026-06-03 — open/close confirmed by next-day OPRA OI.

The strike's open interest rose by +9,212 contracts — almost exactly matching the 9,250-contract BUY. The two-day same-contract DOUBLE-DOWN is now PROVEN: ≈$82M cumulative premium ($41M Mon + $41M Tue) sits on the books at the $190 strike, controlling ≈940K shares of NVDA-equivalent deep-ITM exposure (≈0.95 delta × 9,250 contracts × 100 × 2 days) through the Aug 26 Q2 FY27 earnings binary. This is the cleanest follow-the-whale 2-day pattern in weeks — the desk paid UP each day to OWN this exposure.

---

🤓 What This Actually Means — Plain English

Real talk: someone has now bought the same NVDA $190 September call on back-to-back days, paying more each day as the stock ticked higher. That is not a coincidence. That is a desk with a thesis and a budget, methodically building a leveraged stock-replacement position ahead of the most important earnings print in NVDA's history.

Why a deep-ITM call instead of just buying stock?

At ≈0.95 delta, the $190 call moves almost dollar-for-dollar with NVDA stock — but the buyer controls ≈925,000 shares of NVDA equivalent (9,250 contracts × 100 shares) for ≈$41M in premium instead of the ≈$208M it would cost to buy those shares outright. That is 5× capital efficiency. The trade-off: there is ≈$8.7M of "time value" on today's position alone that bleeds away daily if NVDA sits still. At roughly $9.45 of extrinsic per contract and 108 days to expiration, the theta bill is ≈$80K/day — real money, but tiny relative to the $208M notional exposure.

The earnings angle:

NVDA Q2 FY27 reports August 26, 2026 — 23 calendar days BEFORE the September-18 expiry. That is the whole game. The buyer is not trying to capture weekly gamma; they are paying to own ≈940K shares of NVDA through the Q2 print, where consensus sits at $91B revenue (guided) with whispers at $93–94B, plus first commentary on Vera Rubin customer reservations and Q3 shipment volumes. If NVDA gaps up 10–15% on a Q2 beat, the deep-ITM call participates almost 1-for-1 — that's ≈$22–34/contract of intrinsic appreciation on top of the $35.35 already in the money.

What the 2-day pattern actually signals:

Either (A) the same desk bought yesterday, saw the OI confirm overnight, and went right back in today — that is textbook conviction-building; or (B) a separate whale saw yesterday's OI confirmation and piled on in follow-on. Either way, it is not a one-off. Two consecutive-day blocks on an identical deep-ITM LEAP with a price bump is the cleanest "I really want this exposure" footprint we see in the OPRA tape.

Check yesterday's confirmed-BTO article here: NVDA June 1 — $43M BTO Confirmed

For context on what you'd need for this to lose money:

The $190 call is ≈$35.35 intrinsic today. For the call to be worthless at expiration, NVDA would need to fall below $190 by September 18 — a ≈15.7% decline from $225.35. BofA's bear case for NVDA is ≈$180 (per Arya's range), and the $190 gamma wall is the line-in-the-sand where massive put-side hedging begins. So this buyer is knowingly taking on the "NVDA falls 16%+ AND stays there through Q2 earnings" risk — a scenario that would require either a China B40 escalation, a major macro shock, OR an outright Q2 miss below $91B guide. In exchange, they collect every dollar of upside above $234.80 (their breakeven, which is already ≈$225 intrinsic + $9.45 premium = $234.45).

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

NVDA has recovered strongly from its post-Q1 FY27 earnings pullback (−1.8% day-after print to ≈$219.51 on May 21) and is now trading in the $225–232 range. The stock is essentially flat-to-up since the May-20 earnings print, digesting the beat-and-raise while the market re-calibrates around China H20 headwinds and the Vera Rubin ramp timeline. The two-day whale accumulation on the $190 calls — starting June 1 and continuing today — suggests at least one institutional player believes the digestion phase is nearly complete.

Key observations:

• 🚀 Recovery confirmed: $219 → $225 in under 2 weeks post-earnings
• 🎯 Price hugging the $225 gamma wall — a Very Strong resistance cluster at $225 (128.3 total GEX) is the immediate ceiling; a clean daily close above $225 would be constructive
• 📊 Strong gamma support below: $220 is a Very Strong support wall (138.2 total GEX) — the largest support level in the entire gamma map, just 2.1% below spot
• 💡 The $190 call's notional anchor: The $190 strike itself is a modest Support Wall (29.3 total GEX), meaningful but far below current price — exactly why deep-ITM calls at $190 are pure stock-replacement, not a support-level play

---

Gamma-Based Support and Resistance Analysis

Current Price: ≈$224–225 (GEX reference: $224.32)

The gamma exposure map is dense and layered, which tells you the NVDA options market is extremely well-populated across nearby strikes. Here are the levels that matter most:

🔵 Key Support Levels (Put Gamma / Support Walls Below Price):

Translation: The $220 level is the gamma floor of floors — 138 units of total GEX, the single biggest support cluster in the entire NVDA chain. Dealers are programmatically buying NVDA on dips toward $220. A close below $220 would be a meaningful technical deterioration. The $200 level (88.7 GEX) is the next major floor and lines up with the "disaster scenario" the $190 call buyer would need to experience to go OTM.

🟠 Key Resistance Levels (Call Gamma / Resistance Walls Above Price):

Translation: NVDA is pinned between the $225 resistance wall (128.3 GEX — dealers selling calls into every push toward $225) and the $220 support wall (138.2 GEX — dealers buying puts every time it dips toward $220). To break higher toward the $230 cluster (127.9 GEX), NVDA needs sustained buying that overpowers the $225 ceiling. Once $225 flips to support, the next resistance stack at $230 becomes the target — and after $230, $235 and $240 are Very Strong walls spread over the $235–250 zone.

For the $190 call buyer's thesis: They need NVDA to breach $225 → $230 → $235 sequentially into August, culminating in a Q2 earnings gap-up through $240–$250. The gamma map says that path has real dealer-assisted resistance at each level — but those resistance walls FLIP to support once cleared, which is precisely the kind of staircase rally a deep-ITM call with 108 DTE is positioned to capture.

---

Implied Move Analysis

Options market pricing for upcoming expirations (reference price: $224.20):

What these numbers mean for the whale trade:

The September-18 expiry that the whale bought carries a ±24.5% implied move — meaning the options market is pricing a realistic range of $169.39 to $279.01 by expiration. The upper bound of $279 is directly in line with the BofA / Vivek Arya $320 price target trajectory and the Street consensus of $296.81. The lower bound of $169.39 is BELOW the $190 strike, meaning the options market assigns a non-trivial probability of a sub-$190 scenario — which is why the time value ($9.45/contract) costs as much as it does.

For the $190 call specifically:

• Bull case upper implied target: $279 → call worth ≈$89/contract (+98% from today's $44.80)
• Base case (flat/modest up): $230–$235 → call worth ≈$40–45/contract (roughly breakeven to +5%)
• Bear case lower implied range: $169.39 → call expires worthless (−100% loss on premium)

The ±14.8% monthly implied move through July 17 tells you the Q2 earnings on August 26 is NOT in the July expiry window — but it IS in the September-18 window (23 days of post-earnings runway to expiration). That earnings binary is the dominant driver of today's trade. The whale is not paying ≈$9.45 in time value per contract to own a 3-week trade — they are paying it to own ≈940K NVDA share-equivalents through the most important NVDA print of the year.

---

🎪 Catalysts

🔥 Confirmed Binary — Q2 FY27 Earnings: August 26, 2026

This is THE event the $190 call is positioned for. NVDA confirmed the date on its investor-relations page — Q2 FY27 results after market close, 23 days before September-18 expiry.

The bar is high and climbing:

• Consensus revenue: $91.0B ±2% (guided by NVDA management)
• Street whisper: $93–94B
• Consensus EPS: ≈$2.10
• The Q1 FY27 print already set the template: $81.6B revenue (+85% YoY), $75.2B data center (+92% YoY), adj. EPS $1.87 — all beats

A beat-and-raise to ≈$95–100B Q3 guidance with positive Vera Rubin customer-reservation commentary would be the catalyst for a gap above $240. A miss or in-line print with cautious Rubin commentary (citing CoWoS-L capacity constraints) could see the stock test $210–$215 gamma support.

🚀 Q1 FY27 Print Already Delivered — The Structural Setup

NVDA's May-20 Q1 FY27 was already a historic quarter:

• Revenue: $81.6B vs $78.8B consensus (+3.6% beat), +85% YoY
• Data Center: $75.2B (+92% YoY, +21% sequential) — now ≈92% of total revenue
• Data Center Networking: $14.8B (+199% YoY) — Spectrum-X and NVLink scaling
• Capital return: Board authorized $80B incremental buyback + 2,400% dividend hike ($0.01 → $0.25, payable June 26 to holders of record June 4)

🏭 Vera Rubin / Blackwell Ultra — Product Cycle Tailwind

NVDA confirmed at Computex 2026 that Vera Rubin entered full production "well ahead of schedule" with the NVL72 rack (72 Rubin GPUs + 36 Vera ARM CPUs, NVLink 6, 10× inference throughput at 1/10 the cost-per-token vs Blackwell). First Rubin shipments are expected in Q3 2026 (August–October), volume ramp Q4 2026 — the Aug-26 earnings call will be the first formal opportunity for Jensen to give customer-reservation color on Rubin volumes. That commentary will move the stock regardless of the headline revenue number.

🌍 Sovereign AI Deals — New Demand Stack Activated

• Saudi Arabia HUMAIN: "several hundred thousand" NVIDIA GPUs over 5 years, starting with 18,000 GB300 supercluster (500 MW total capacity)
• Stargate UAE (G42 + OpenAI + Oracle + Cisco + NVIDIA): 1 GW total, first 200 MW live in 2026 with GB300 systems

📈 Analyst Consensus — Overwhelmingly Bullish

38 Buy / 1 Hold / 1 Sell per MarketBeat, consensus PT $296.81 (+31.5% upside from $225). BofA's Vivek Arya raised PT to $320 from $300 on May 13 after lifting his 2030 AI data-center TAM estimate from $1.4T to $1.7T. PT range: $180 bear to $500 bull — the $320 analyst consensus sits just above the Sep-18 implied upper range of $279.

💸 Hyperscaler Capex — The Demand Engine

The Big Five hyperscalers have committed a combined ≈$600–700B of 2026 capex (+36% YoY), of which ≈75% is AI infrastructure — Microsoft $80B, Google $75B, Meta $60–65B, Amazon ≈$200B, Oracle $35–40B. At NVDA's ≈$170–190B FY26 data-center revenue run-rate, that is still under 40% wallet capture — plenty of headroom for continued growth.

⚠️ Risk Catalysts — What Could Hurt This Trade

China H20 / B40 policy escalation: The H20 ban already cost NVDA $4.5B inventory writedown + $8B of lost Q2 revenue guidance. Any further U.S. tightening targeting the B40 or downstream China AI SKUs could punch another $5–10B hole in FY27 revenue — the single biggest known unknown in the thesis.

AMD MI400 — the credible 2026 challenger: AMD's MI455X / MI430X series arrives end-2026 with 432GB HBM4 / 19.6 TB/s — 2.25× the memory and 2.4× the bandwidth of the B200. This is the first GPU competitive threat that attacks NVDA's memory-bandwidth moat on memory-bound inference (≈30–40% of inference workloads). MI400 lands in the same window as Rubin volume — the Sept-18 expiry just barely escapes the head-to-head pricing pressure.

Broadcom XPU — custom-silicon encroachment: AVGO AI revenue $8.4B in Q2 FY26 (+106% YoY), $73B backlog through mid-2027, 6 confirmed XPU customers. OpenAI's 10 GW first-deploy 2H 2026 is the test case for custom ASIC economics vs NVDA merchant silicon.

CoWoS-L / HBM4 supply constraints: Rubin volume ramp in Q4 2026 is gated on TSMC AP6 capacity — any slippage shifts revenue right and could mute the Aug-26 beat potential.

---

🎲 Price Targets and Probabilities

Using gamma levels, implied move data, and the Sep-18 expiry window:

📈 Bull Case (35% probability)

Target: $260–$279 by Sep-18

NVDA beats Q2 at $93–95B, raises Q3 guide above $100B, and Jensen delivers strong Vera Rubin customer-reservation commentary on Aug-26. Stock gaps above $240 (Very Strong resistance/next gamma cluster), then consolidates and grinds through $250–$260 into the September-18 expiry.

$190 call value at $260: ≈$70 (+56% from $44.80 cost) — the deep-ITM leverage working in the buyer's favor.

$190 call value at $279 (implied upper range): ≈$89 (+99% — near doubling).

What it takes: Beat + raise on Aug-26, Rubin shipment volumes above Street estimates, no new China policy shocks, hyperscaler capex commentary stays constructive.

🎯 Base Case (45% probability)

Target: $225–$250 by Sep-18 (chop and grind)

NVDA delivers Q2 roughly in line at $91–93B, gives a solid but not spectacular Q3 guide, and the market treats it as "priced in." Stock stays in the $225–$240 range through most of summer, possibly reaching $245–$250 on a quiet post-earnings drift as Rubin shipment data trickes out.

$190 call value at $235 (nut-cracker base): ≈$47–50 (up ≈$2–5 from cost — basically breakeven to modest gain after theta bleed).

$190 call value at $245 (upper base): ≈$55–58 (+22–30%).

The theta reality: At ≈$80K theta per day on the 9,250-contract position, 108 days of slow grind with NVDA staying at $225 would consume most of the $8.7M of extrinsic. The buyer needs NVDA to move, not stand still.

📉 Bear Case (20% probability)

Target: $190–$215 by Sep-18 (call goes to zero or near-zero)

China B40 escalation removes another $5–10B from FY27 revenue, AMD MI400 pre-announcement poaches a major hyperscaler customer, or NVDA delivers a Q2 miss + cautious Rubin guide. Stock tests the $210 gamma wall ($210 is Very Strong support, 66.5 GEX), then possibly $200 (88.7 GEX support wall). Below $190, the call expires worthless.

$190 call value at $200: ≈$10 (−78% loss on $44.80 cost — deep out of time value, 8 cents of intrinsic).

$190 call value at $190: ≈$0–1 (−100% loss).

For the bear case to destroy the trade: NVDA would need to fall ≈15.7% from today's $225.35 AND stay below $190 through September-18. The $200 gamma wall (88.7 GEX = Very Strong) is the last major support before $190 — that wall would need to be decisively broken.

---

💡 Trading Ideas

🛡️ Conservative: The "Same Thesis, Less Capital" Approach

Play: Rather than the deep-ITM $190 call, consider a bull call spread that costs a fraction of the premium.

Example structure: Buy the NVDA $225 call / Sell the $250 call, September-18 expiration.

• Why this works: You're in the same expiry window (capturing the Aug-26 earnings binary) but with a defined-risk $25-wide spread instead of a $44.80/contract single-leg bet. Your max loss is limited to the debit paid, and your max profit is the full $25 spread width if NVDA closes above $250 at expiry.
• Who it's for: If you believe the bull case (NVDA $250+ by September) but don't want to commit to the full $44.80 ticket, this gives you participation at a fraction of the cost.
• Rough cost: ≈$10–12/spread. Max profit ≈$13–15/spread (≈120% ROI in the bull case vs NVDA staying flat = max loss).

Risk level: Moderate-low (defined max loss) | Skill level: Intermediate

⚖️ Balanced: The "Follow the Whale, Smaller Size" Approach

Play: Buy 5–10 contracts of the NVDA $190 September-18 call outright, mirroring the whale's exact trade — just at retail sizing.

Why this works:

• 🎯 You are copying the exact structure and expiry the whale chose — deep-ITM stock replacement with the Q2 earnings binary inside the window
• 💡 5 contracts costs ≈$22,400 (5 × $44.80 × 100) and controls 500 NVDA share-equivalents through earnings
• 📅 Check the OI update June 3 pre-market to confirm today's print was also BTO before entering — that confirmation de-risks the follow-on trade materially

Risk: You lose ≈$22,400 if NVDA closes below $190 on September-18. This is a real risk. NVDA at $190 would be a ≈15.7% decline. It happened in May 2024 and March 2025.

Risk level: Moderate-high (can lose entire premium) | Skill level: Intermediate-Advanced

🚀 Aggressive: The Gamma-Breakout Play

Play: Buy NVDA $230 calls, September-18 or August-21 expiration, betting on a breakout above the $230 Very Strong resistance wall (127.9 GEX).

Why this is aggressive:

• If NVDA clears $225 (128.3 GEX) and then $230 (127.9 GEX), those former resistance walls flip to support — and the path to $240–$245 opens up
• But if NVDA stalls at $225 and bleeds back to $220 for the next 4–6 weeks, your OTM $230 call bleeds theta every day with no intrinsic to cushion the loss
• These are pure-delta-and-theta bets — a very different risk profile from the whale's deep-ITM stock-replacement position

Risk level: High (can lose most or all premium if NVDA stays range-bound) | Skill level: Advanced

---

⚠️ Risk Factors

Don't enter the trade without staring these in the face:

• 🇨🇳 China B40 / additional export controls: The H20 ban cost NVDA $4.5B + $8B Q2 revenue hit. A further tightening targeting B40 chips or China AI SKUs would punch a $5–10B incremental hole in FY27 revenue — and China was 12.5% of Q1 revenue. This is the tail risk that cannot be priced until it happens.

• 🔩 CoWoS-L / HBM4 supply constraint: TSMC's AP6 fab ramp and AP3 conversion gate Rubin volume in Q4. If TSMC signals capacity slippage on the Aug-26 call, NVDA's Q3/Q4 FY27 guidance will disappoint — and a "beat Q2 but miss the Q3 setup" print is the nightmare scenario for the $190 call.

• 🤖 AMD MI400 / Broadcom XPU / Google TPU-7 — the credibility threat: AMD MI400 (432GB HBM4, 19.6 TB/s), Broadcom's $73B custom XPU backlog, and Google's TPU-7 Ironwood at 4,614 FP8 TFLOPS all arrive 2H 2026. None of these kills NVDA's Rubin NVL72 networking advantage, but any one of them winning a headline hyperscaler contract announcement BEFORE August 26 would create a "share shift" narrative overhang.

• 💸 Time value bleed — the $8.7M daily tax: Today's 9,250-contract position has ≈$8.7M of pure extrinsic premium (9,250 × $9.45 × 100 shares). At 108 DTE, that is roughly ≈$80,000/day of theta decay if NVDA sits completely still. The whale can afford to pay that "rent" on their leveraged exposure. Retail traders copying the trade in smaller size should understand they face the same per-contract theta.

• 📉 NVDA below $220 pressures the thesis: The $220 gamma wall (138.2 GEX — largest support) is the line in the sand. If NVDA breaks and closes below $220 on sustained volume, the stock-replacement thesis starts looking expensive relative to just owning stock. A dip to $215 or $210 before the August 26 print would cost the $190 call buyer ≈$10–15/contract of intrinsic (though the position would still be in the money at those levels).

• 📊 $5.5T market cap — the bar for "surprise" is structurally higher: At ≈24× FY27 revenue estimates, NVDA is priced for sustained perfection. A $91B Q2 in-line print with flat Q3 guide would likely be "sell the news" — the stock needs a raise AND positive product commentary to gap meaningfully higher.

---

🎯 The Bottom Line

Here's the deal: Two consecutive days. The same exact contract. A second $41M block crossing the tape today at $44.80, paid up $1.50/contract from yesterday. The OPRA OI confirmed yesterday's print as a fresh long (Δ +9,356). If today confirms the same way — and the 2-day pattern makes it nearly certain — then a single desk (or two coordinated desks with identical theses) now controls ≈940,000 NVDA share-equivalents through September-18 for ≈$84M in total premium.

This is not speculative gamma trading. A ≈0.95-delta deep-ITM call that tracks stock dollar-for-dollar is about as close to "I want to own NVDA stock but with 5× capital efficiency" as you can get in the options market. The buyer chose September-18 SPECIFICALLY because NVDA Q2 FY27 earnings are August 26 — 23 days before expiry. They are paying ≈$9.45/contract of time value to own that leverage through the biggest NVDA print of the year, on a stock where the consensus price target is $296.81, BofA's Arya has a $320 target, and Vera Rubin volume ramp in Q4 2026 is the next leg of the structural demand story.

If you own NVDA:

• ✅ The two-day whale accumulation is institutional validation of the $225–$230 support zone; it suggests smart money views the post-earnings dip as a buying opportunity, not a warning sign
• 📊 Watch the $225 resistance wall — a daily close above $225 on strong volume would signal the next leg toward $230–$235 and confirm the whales are right
• 📅 Mark August 26 as your binary event date. Hold through earnings for the full catalyst; trim afterward if the guidance tone is cautious

If you're watching from the sidelines:

• ⏳ Wait for the June 3 OI confirmation (≈06:30 ET) before entering any follow-on trade. If OI rises ≈+9,000, the second-wave thesis is confirmed — that is your entry signal
• 🎯 Bull case entry points: above $225 (breakout above Very Strong resistance) with a target of $235–$240 before earnings; or a dip toward $220 (Very Strong gamma support, 138.2 GEX) as a risk-managed accumulation zone
• ⚠️ Do NOT chase the $190 call at current prices unless you have sized it appropriately (risk no more than 2–5% of your portfolio — this is a high-conviction institutional position, not a diversified strategy)

Mark your calendar:

• 📅 June 3 pre-market (≈06:30 ET): OPRA OI update — confirm today's BTO or flag for re-analysis
• 📅 June 4: NVDA dividend record date ($0.25/share, payable June 26 — note: calls generally do NOT benefit from dividends; the ex-date can cause a small downward adjustment in call pricing)
• 📅 Late August: Hot Chips 2026 — typically heavy NVDA disclosure on next-gen networking/optical
• 📅 August 26 AMC: NVDA Q2 FY27 earnings — THE binary
• 📅 September 18: This call expires (Triple Witch OPEX)

Final verdict: The ≈$84M cumulative two-day block-cross on the NVDA $190 September-18 call is the cleanest follow-on-conviction footprint in the OPRA tape this week. A desk that paid $43.30 on Monday, watched the OI confirm overnight, and then paid $44.80 on Tuesday is not second-guessing the trade — they are adding to it. The fundamental setup ($81.6B Q1 beat, $80B buyback, Vera Rubin production ramp, sovereign AI pipeline, $600B+ hyperscaler capex tailwind) supports the thesis. The tail risks (China, AMD, supply) are real and should not be dismissed — but this desk clearly believes the August 26 Q2 print resolves them bullishly.

Come back June 3 pre-market. If OI confirms, the second wave is real. 💪

---

👥 4-Reader Perspectives

🎰 YOLO Trader

"Bro two consecutive days of ≈$40M blocks on the same NVDA call?? That's ≈$84M cumulative and the desk is STILL buying — check the OI confirmation June 3 AM, and if it pops to 99K+ contracts, load the $230 September calls and ride the momentum into earnings August 26. The gamma map shows $225 and $230 are huge resistance walls, but once those break, $240–$250 is wide open. This is the pre-earnings ramp trade. Risk management still applies — don't bet the farm."

📊 Swing Trader

"Two confirmed institutional block crosses on a deep-ITM September call with earnings inside the window. The trade signal is clear: the desk wants leveraged NVDA exposure through Q2. My play: watch for a clean daily close above $225 (first major resistance), confirm June 3 OI, then enter the $190 or $200 call with a 3–5% position size and set a mental stop at a close below $218. Target: $240–$250 before August 26. Trim 50% going into earnings and let the rest ride the print."

💼 Premium Collector

"At $5.5T market cap and with two big block crosses confirming demand at the $225 level, the gamma map tells me $220 (138.2 GEX Very Strong) is a durable floor and $225–$230 is strong resistance. I'll sell a put spread: sell the NVDA $215 put / buy the $205 put, September-18 expiration. Collect the credit for the August 26 earnings binary, with the $200 gamma wall (88.7 GEX) as a backstop below my short strike. Max risk is defined; if NVDA stays above $215 into Sept-18, I keep the full credit."

🌱 Entry-Level / Beginner

"Here's what just happened in plain English: a very wealthy institution spent ≈$84M over two days buying the right to own the equivalent of almost a million NVIDIA shares through mid-September. They did it through options instead of stock to use less capital — think of it like a big down payment that gives them stock-like exposure. The key event everyone is waiting for is NVIDIA's Q2 earnings on August 26 — if NVIDIA reports more than $91B of revenue and raises guidance again, the stock could push toward $240–$260 by September and the whale makes a lot of money. If NVIDIA disappoints (say a China trade-war shock), the call can lose a lot of value. You do NOT need to copy this trade directly. The takeaway for beginners: watch August 26 earnings closely, and understand that when you see two consecutive days of ≈$40M blocks in the same contract, it means a serious investor is very confident in the direction."

---

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice. The ⏳ BTO classification for today's print is provisional and will be confirmed or revised based on the June 3 OPRA open-interest update. Always conduct your own research and consult a licensed financial advisor before trading. Past unusual options activity does not guarantee future stock performance. Deep-ITM long calls can lose the majority of their value in adverse scenarios.

---

Last updated: 2026-06-02 | Next update: ≈2026-06-03 06:30 ET (OPRA OI confirmation)

NVDA on AInvest | NVDA20260918C190 Option Chart